Incretin Mimetics and Dipeptidyl Peptidase‐IV Inhibitors: Potential New Therapies for Type 2 Diabetes Mellitus
Authors:
- 1 March 2006
- journal article
- review article
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 26 (3) , 360-374
Abstract
The emergence of the glucoregulatory hormones glucagon‐like peptide‐1 (GLP‐1) and glucose‐dependent insulinotropic polypeptide has expanded our understanding of glucose homeostasis. In particular, the glucoregulatory actions of the incretin hormone GLP‐1 include enhancement of glucose‐dependent insulin secretion, suppression of inappropriately elevated glucagon secretion, slowing of gastric emptying, and reduction of food intake. Two approaches have been developed to overcome rapid degradation of GLP‐1. One is the use of agents that mimic the enhancement of glucose‐dependent insulin secretion, and potentially other antihyperglycemic actions of incretins, and the other is the use of dipeptidyl peptidase‐IV inhibitors, which reduce the inactivation of GLP‐1, increasing the concentration of endogenous GLP‐1. The development of incretin mimetics and dipeptidyl peptidase‐IV inhibitors opens the door to a new generation of antihyperglycemic agents to treat several otherwise unaddressed pathophysiologic defects of type 2 diabetes mellitus. We review the physiology of glucose homeostasis, emphasizing the role of GLP‐1, the pathophysiology of type 2 diabetes mellitus, the clinical shortcomings of current therapies, and the potential of new therapies— including the newly approved incretin mimetic exenatide—that elicit actions similar to those of GLP‐1.Keywords
This publication has 76 references indexed in Scilit:
- ExenatideDrugs, 2005
- Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Sulfonylurea-Treated Patients With Type 2 DiabetesDiabetes Care, 2004
- Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humansAmerican Journal of Physiology-Endocrinology and Metabolism, 2004
- GIF biology and fat metabolismLife Sciences, 1999
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)The Lancet, 1998
- Rapid Gastric Emptying of a Solid Pancake Meal in Type II Diabetic PatientsDiabetes Care, 1996
- A role for glucagon-like peptide-1 in the central regulation of feedingNature, 1996
- Glucose modulation of insulin and glucagon secretion is altered in impaired glucose toleranceThe Journal of Clinical Endocrinology & Metabolism, 1995
- lnsulinotropic action of truncated glucagon‐like peptide‐1 in miceActa Physiologica Scandinavica, 1995
- Glucagon and the a CellNew England Journal of Medicine, 1981